Related references
Note: Only part of the references are listed.A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective?
Mohsen Nabi-Afjadi et al.
INFLAMMOPHARMACOLOGY (2023)
Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota
William Fusco et al.
NUTRIENTS (2023)
The Interplay of Dietary Fibers and Intestinal Microbiota Affects Type 2 Diabetes by Generating Short-Chain Fatty Acids
Muhammad Mazhar et al.
FOODS (2023)
Exploring the Association between Citrus Nutraceutical Eriocitrin and Metformin for Improving Pre-Diabetes in a Dynamic Microbiome Model
Thais Cesar et al.
PHARMACEUTICALS (2023)
Fiber supplementation protects from antibiotic-induced gut microbiome dysbiosis by modulating gut redox potential
Swathi Penumutchu et al.
NATURE COMMUNICATIONS (2023)
Production of short-chain fatty acids (SCFAs) as chemicals or substrates for microbes to obtain biochemicals
Elia Tomas-Pejo et al.
BIOTECHNOLOGY FOR BIOFUELS AND BIOPRODUCTS (2023)
The mechanisms of action of ivermectin against SARS-CoV-2-an extensive review
Asiya Kamber Zaidi et al.
JOURNAL OF ANTIBIOTICS (2022)
Ivermectin for mass drug administration against malaria
Pauline Byakika-Kibwika et al.
LANCET INFECTIOUS DISEASES (2022)
Prevalence and antimicrobial resistance pattern of Clostridium difficile among hospitalized diarrheal patients: A systematic review and meta-analysis
Tebelay Dilnessa et al.
PLOS ONE (2022)
Ivermectin for the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Yuani M. Roman et al.
CLINICAL INFECTIOUS DISEASES (2022)
Different gut microbial communities correlate with efficacy of albendazole-ivermectin against soil-transmitted helminthiases
Pierre H. H. Schneeberger et al.
NATURE COMMUNICATIONS (2022)
Analysis of the Ability of Capsaicin to Modulate the Human Gut Microbiota In Vitro
Karley K. Mahalak et al.
NUTRIENTS (2022)
Could the COVID-19-Driven Increased Use of Ivermectin Lead to Incidents of Imbalanced Gut Microbiota and Dysbiosis?
Leon M. T. Dicks et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2022)
Persistence of the Probiotic Lacticaseibacillus rhamnosus Strain GG (LGG) in an In Vitro Model of the Gut Microbiome
Karley K. Mahalak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Helminths and Bacterial Microbiota: The Interactions of Two of Humans' Old Friends
Kevin Llinas-Caballero et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Repurposing the drug, ivermectin, in COVID-19: toxicological points of view
Farshad M. Shirazi et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2022)
Ivermectin (IVM) Possible Side Activities and Implications in Antimicrobial Resistance and Animal Welfare: The Authors' Perspective
Cristian Piras et al.
VETERINARY SCIENCES (2022)
Ivermectin, a potential anticancer drug derived from an antiparasitic drug
Mingyang Tang et al.
PHARMACOLOGICAL RESEARCH (2021)
Ivermectin: An Anthelmintic, an Insecticide, and Much More
Richard J. Martin et al.
TRENDS IN PARASITOLOGY (2021)
Micronutrients impact the gut microbiota and blood glucose
Nicole G. Barra et al.
JOURNAL OF ENDOCRINOLOGY (2021)
Helminth extracellular vesicles: Interactions with the host immune system
Claire Drurey et al.
MOLECULAR IMMUNOLOGY (2021)
Distal colonic transit is linked to gut microbiota diversity and microbial fermentation in humans with slow colonic transit
Mattea Muller et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)
Harnessing the gut microbiome in the fight against anthelminthic drug resistance
Thomas J. Sharpton et al.
CURRENT OPINION IN MICROBIOLOGY (2020)
Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma
Liang Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
PICRUSt2 for prediction of metagenome functions
Gavin M. Douglas et al.
NATURE BIOTECHNOLOGY (2020)
The impact of anthelmintic treatment on gut bacterial and fungal communities in diagnosed parasite-free sika deer Cervus nippon
Xiaolong Hu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)
Triclosan has a robust, yet reversible impact on human gut microbial compositionin vitro
Karley K. Mahalak et al.
PLOS ONE (2020)
Short-chain fatty acids production by Bifidobacterium species in the presence of salep
Buse Usta-Gorgun et al.
ELECTRONIC JOURNAL OF BIOTECHNOLOGY (2020)
Ivermectin inhibits extracellular vesicle secretion from parasitic nematodes
Hannah J. Loghry et al.
JOURNAL OF EXTRACELLULAR VESICLES (2020)
Helminth infections of great concern among cattle in Nigeria: Insight to its prevalence, species diversity, patterns of infections and risk factors
Shola David Ola-Fadunsin et al.
VETERINARY WORLD (2020)
A systematic review on modelling approaches for economic losses studies caused by parasites and their associated diseases in cattle
Muhammad Rashid et al.
PARASITOLOGY (2019)
Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial
Brian D. Foy et al.
LANCET (2019)
Drug Repurposing for the Treatment of Bacterial and Fungal Infections
Andrea Miro-Canturri et al.
FRONTIERS IN MICROBIOLOGY (2019)
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
Evan Bolyen et al.
NATURE BIOTECHNOLOGY (2019)
Regional Diversity of the Gastrointestinal Microbiome
Kristina Martinez-Guryn et al.
CELL HOST & MICROBE (2019)
Ivermectin and its target molecules: shared and unique modulation mechanisms of ion channels and receptors by ivermectin
I-Shan Chen et al.
JOURNAL OF PHYSIOLOGY-LONDON (2018)
Establishing a mucosal gut microbial community in vitro using an artificial simulator
LinShu Liu et al.
PLOS ONE (2018)
Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota
Pierre H. H. Schneeberger et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
In vitro activity of ivermectin against Staphylococcus aureus clinical isolates
Shoaib Ashraf et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2018)
Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2′s q2-feature-classifier plugin
Nicholas A. Bokulich et al.
MICROBIOME (2018)
Low Microfilaremia Levels in Three Districts in Coastal Ghana with at Least 16 Years of Mass Drug Administration and Persistent Transmission of Lymphatic Filariasis
Dziedzom K. de Souza et al.
TROPICAL MEDICINE AND INFECTIOUS DISEASE (2018)
Formation of propionate and butyrate by the human colonic microbiota
Petra Louis et al.
ENVIRONMENTAL MICROBIOLOGY (2017)
DADA2: High-resolution sample inference from Illumina amplicon data
Benjamin J. Callahan et al.
NATURE METHODS (2016)
New developments in the treatment of rosacea - role of once-daily ivermectin cream
Leah A. Cardwell et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2016)
TEER Measurement Techniques for In Vitro Barrier Model Systems
Balaji Srinivasan et al.
JALA (2015)
Unique aspects of fiber degradation by the ruminal ethanologen Ruminococcus albus 7 revealed by physiological and transcriptomic analysis
Melissa R. Christopherson et al.
BMC GENOMICS (2014)
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Kazutaka Katoh et al.
MOLECULAR BIOLOGY AND EVOLUTION (2013)
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
Christian Quast et al.
NUCLEIC ACIDS RESEARCH (2013)
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
Kylie M. Wagstaff et al.
BIOCHEMICAL JOURNAL (2012)
An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea
Daniel McDonald et al.
ISME JOURNAL (2012)
Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by lactobacilli
Pieter Van den Abbeele et al.
MICROBIAL BIOTECHNOLOGY (2012)
Ivermectin, 'Wonder drug' from Japan: the human use perspective
Andy Crump et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2011)
The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells
Sumaiya Sharmeen et al.
BLOOD (2010)
Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice
X. Zhang et al.
INFLAMMATION RESEARCH (2008)
Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities
Catherine A. Lozupone et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
UniFrac: a new phylogenetic method for comparing microbial communities
C Lozupone et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
Intestinal secretion is a major route for parent ivermectin elimination in the rat
C Laffont et al.
DRUG METABOLISM AND DISPOSITION (2002)
Ivermectin: effectiveness in lymphatic filariasis
KR Brown et al.
PARASITOLOGY (2000)